Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP951622priorityCriticalpatent/ECSP951622A/en
Publication of ECSP951622ApublicationCriticalpatent/ECSP951622A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Se refiere a derivados de ácido acéptico a procedimientos para su preparación, a composiciones farmacéuticas que contienen tales compuestos y a su uso en medicina.It refers to derivatives of acetic acid, to processes for their preparation, to pharmaceutical compositions containing such compounds and to their use in medicine.
1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
A SALT OF A COMPOUND DERIVED FROM CARBOXYLLIC NAFTIRIDINE ACID, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURE TO PREPARE IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
25-carboxylic acid derivatives of the vitamin D series, methods for their preparation, intermediates used in these methods, pharmaceutical preparations containing these derivatives and the use of these derivatives for the preparation of pharmaceuticals
DERIVATIVES OF FENIL-4-TIAZOLES SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND DERIVATIVES DEFENIL-4-TIAZOLES SUBSTITUTED USED IN SUCH PROCEDURE.
Compound, pharmaceutical composition, use of a compound, processes to treat or prevent diseases of the endocrinological system, to manufacture a drug, to prepare a compound and a set, and use of it.
6-fluoro-3,5-dihydroxycarboxylic acids and their derivatives, processes for their preparation, their use as pharmaceuticals, pharmaceutical preparations and intermediates.
NEW ACID DERIVATIVES OF PYRAZOLE, METHOD FOR THEIR PRODUCTION, THEIR USE AS MEDICATIONS, THEIR NEW USE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM